{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:29:05Z","timestamp":1777044545433,"version":"3.51.4"},"reference-count":31,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"\n Background & objectives:<\/jats:title>\n \n Clostridium difficile<\/jats:italic> is the primary cause of hospital-acquired colitis in patients receiving antibiotics. The pathogenicity of the organism is mainly due to the production of toxins. This study was conducted to investigate the presence of toxigenic C. difficile<\/jats:italic> in the faecal samples of hospitalized patients suspected to have C. difficile<\/jats:italic> infection (CDI) and corroborating the findings with their clinical and demographic data.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Diarrhoeic samples obtained from 1110 hospitalized patients were cultured for C. difficile<\/jats:italic> and the isolates confirmed by phenotypic and molecular methods. Toxigenicity of the isolates was determined using enzyme-linked immunosorbent assay for toxins A and B. Details of patients included in the study were noted and analyzed.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Of the 1110 patients (mean age 39\u00b119.6 yr), 63.9 per cent were males and 36.1 per cent were females. The major antibiotics received by the patients were nitazoxanide (23.9%), penicillins\/penicillin combinations (19.0%), quinolones including fluoroquinolones (13.1%), carbapenems (11.5%), glycopeptides (11.0%) and cephalosporins (8.4%). The clinical symptoms predominantly present were watery diarrhoea (56.4%), fever (40.0%) and abdominal pain (35.3%). The underlying diseases were gastrointestinal disorders (52.6%), followed by cancers (13.2%), surgical conditions (8.3%), and hepatic disorders (8.0%). Of the 174 C. difficile<\/jats:italic> isolates, 54.6 per cent were toxigenic. Toxigenic C. difficile<\/jats:italic> was present in all patients with surgical conditions, 65.2 per cent with cancers and 57.1 per cent with gastrointestinal disorders.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n \n C. difficile<\/jats:italic> was found to be an important cause of gastrointestinal infections in hospitalized patients with underlying diseases and on antibiotics. Clinical conditions of the patients correlating with toxigenic culture can be an important tool for establishing CDI diagnosis.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_192_16","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T12:46:48Z","timestamp":1519217208000},"page":"840-846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre"],"prefix":"10.25259","volume":"145","author":[{"given":"Meenakshi","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetana","family":"Vaishnavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safrun","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-20-20241212","first-page":"346","article-title":"What have we learnt about antimicrobial use and the risk for Clostridium difficile-associated diarrhea?","volume":"21","author":"Blondeau","year":"2008","journal-title":"J Pharm Practice"},{"key":"R2-20-20241212","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2036.2006.03015.x","article-title":"Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea","volume":"24","author":"Yearsley","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R3-20-20241212","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1440-1746.2009.06135.x","article-title":"Effect of biotherapeutics on cyclosporin-induced Clostridium difficile infection in mice","volume":"25","author":"Kaur","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"R4-20-20241212","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157489112801619674","article-title":"The evolution of Clostridium difficile infection in cancer patients: epidemiology, pathophysiology, and guidelines for prevention and management","volume":"7","author":"Khan","year":"2012","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"R5-20-20241212","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/MCG.0b013e31803d16ec","article-title":"Clostridium difficile: Old and new observations","volume":"41","author":"Bartlett","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"R6-20-20241212","first-page":"13","article-title":"Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis","volume":"24","author":"Vaishnavi","year":"2003","journal-title":"Trop Gastroenterol"},{"key":"R7-20-20241212","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1473-3099(08)70233-0","article-title":"Diagnosis of Clostridium difficile infection by toxin detection kits: A systematic review","volume":"8","author":"Planche","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R8-20-20241212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1099\/jmm.0.45844-0","article-title":"Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture","volume":"54","author":"Delm\u00e9e","year":"2005","journal-title":"J Med Microbiol"},{"key":"R9-20-20241212","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4236\/aim.2015.55034","article-title":"Surveillance for antibiotic resistance in Clostridium difficile strains isolated from patients in a tertiary care center","volume":"5","author":"Singh","year":"2015","journal-title":"Adv Microbiol"},{"key":"R10-20-20241212","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2008.78.577","article-title":"PCR detection of Clostridium difficile triose phosphate isomerise (tpi), toxin A (tcdA), toxin B (tcdB), binary toxin (cdtA, cdtB), and tcdC genes in Vhembe District, South Africa","volume":"78","author":"Samie","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"R11-20-20241212","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S1286-4579(00)01343-5","article-title":"Clostridium difficile toxin and faecal lactoferrin assays in adult patients","volume":"2","author":"Vaishnavi","year":"2000","journal-title":"Microbes Infect"},{"key":"R12-20-20241212","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4103\/0255-0857.55436","article-title":"Established and potential risk factors for Clostridum difficile infection","volume":"27","author":"Vaishnavi","year":"2009","journal-title":"Indian J Med Microbiol"},{"key":"R13-20-20241212","first-page":"750","article-title":"Strategies for management of Clostridium difficile infection in immunosuppressed patients","volume":"7","author":"Binion","year":"2011","journal-title":"Gastroenterol Hepatol (N Y"},{"key":"R14-20-20241212","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1525-1438.1999.99065.x","article-title":"Fulminant Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy","volume":"9","author":"Resnik","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"R15-20-20241212","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/0255-0857.153570","article-title":"Clinical and demographic profile of patients reporting for Clostridium difficile infection in a tertiary care hospital","volume":"33","author":"Vaishnavi","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"R16-20-20241212","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1086\/521863","article-title":"Clinical recognition and diagnosis of Clostridium difficile infection","volume":"46","author":"Bartlett","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R17-20-20241212","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/520276","article-title":"Clostridium difficile \u2013 Associated diarrhea","volume":"26","author":"Johnson","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R18-20-20241212","first-page":"518","article-title":"Diagnostic role of stool culture & toxin detection in antibiotic associated diarrhoea due to Clostridium difficile in children","volume":"122","author":"Gogate","year":"2005","journal-title":"Indian J Med Res"},{"key":"R19-20-20241212","first-page":"487","article-title":"Clinical spectrum & pathogenesis of Clostridium difficile associated diseases","volume":"131","author":"Vaishnavi","year":"2010","journal-title":"Indian J Med Res"},{"key":"R20-20-20241212","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1089\/sur.2006.062","article-title":"The burden of Clostridium difficile in surgical patients in the United States","volume":"8","author":"Zerey","year":"2007","journal-title":"Surg Infect (Larchmt"},{"key":"R21-20-20241212","first-page":"773","article-title":"Risk factors for Clostridium difficile-associated diarrhea among cancer patients","volume":"36","author":"Zhu","year":"2014","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R22-20-20241212","first-page":"248","article-title":"Prevalence of toxin A negative\/B positive Clostridium difficile strains","volume":"42","author":"Brazier","year":"1999","journal-title":"J Hosp Infect"},{"key":"R23-20-20241212","first-page":"16","article-title":"Prevalence of Clostridium difficile in hospitalised patients with acute diarrhoea in Calcutta","volume":"9","author":"Niyogi","year":"1991","journal-title":"J Diarrhoeal Dis Res"},{"key":"R24-20-20241212","first-page":"377","article-title":"Changing pattern of Clostridium difficile associated diarrhoea in a tertiary care hospital: A 5 year retrospective study","volume":"127","author":"Chaudhry","year":"2008","journal-title":"Indian J Med Res"},{"key":"R25-20-20241212","first-page":"804","article-title":"Clostridium difficile infection at a tertiary care hospital in South India","volume":"61","author":"Vishwanath","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"R26-20-20241212","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12664-011-0097-5","article-title":"Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: A retrospective analysis","volume":"30","author":"Ingle","year":"2011","journal-title":"Indian J Gastroenterol"},{"key":"R27-20-20241212","first-page":"26","article-title":"Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital","volume":"60","author":"Kaneria","year":"2012","journal-title":"J Assoc Physicians India"},{"key":"R28-20-20241212","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1099\/jmm.0.000169","article-title":"Prevalence and molecular types of Clostridium difficile isolates from faecal specimens of patients in a tertiary care centre","volume":"64","author":"Vaishnavi","year":"2015","journal-title":"J Med Microbiol"},{"key":"R29-20-20241212","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1099\/jmm.0.000125-0","article-title":"Detection and characterization of Clostridium difficile from patients with antibiotic-associated diarrhoea in a tertiary care hospital in North India","volume":"58","author":"Joshy","year":"2009","journal-title":"J Med Microbiol"},{"key":"R30-20-20241212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R31-20-20241212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2329-9126.1000171","article-title":"Newer diagnostic methods in Clostridium difficile infection","volume":"2","author":"Vaishnavi","year":"2014","journal-title":"J Gen Practice"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201745060-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:59:01Z","timestamp":1751497141000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/toxigenic-clostridium-difficile-isolates-from-clinically-significant-diarrhoea-in-patients-from-a-tertiary-care-centre\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_192_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}